Physiological Effects of Drugs Not Yet Recruiting Phase 2 Trials for Omalizumab (DB00043)

IndicationStatusPhase
DBCOND0033861 (Physiological Effects of Drugs)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04045301Omalizumab to Accelerate a Symptom-driven Multi-food OITTreatment